Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to $28.4 million.

  • Iridex's Liabilities and Shareholders Equity fell 597.27% to $28.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.3 million, marking a year-over-year decrease of 509.66%. This contributed to the annual value of $29.1 million for FY2024, which is 1539.38% down from last year.
  • Per Iridex's latest filing, its Liabilities and Shareholders Equity stood at $28.4 million for Q3 2025, which was down 597.27% from $31.6 million recorded in Q2 2025.
  • Iridex's Liabilities and Shareholders Equity's 5-year high stood at $50.5 million during Q4 2021, with a 5-year trough of $28.0 million in Q1 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $35.9 million (2023), whereas its average is $38.7 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 7759.58% in 2021, then plummeted by 2226.47% in 2023.
  • Over the past 5 years, Iridex's Liabilities and Shareholders Equity (Quarter) stood at $50.5 million in 2021, then fell by 16.33% to $42.3 million in 2022, then decreased by 18.57% to $34.4 million in 2023, then decreased by 15.39% to $29.1 million in 2024, then decreased by 2.68% to $28.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $28.4 million in Q3 2025, compared to $31.6 million in Q2 2025 and $34.2 million in Q1 2025.